Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 40 min ago
Peer-reviewedLicence not statedJournal of Managed Care & Specialty Pharmacy

Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit

  1. 1Blue Cross Blue Shield of Michigan, Detroit

Related

  1. Pathways to medication adherence: a configurational analysis of psychiatric symptoms and medication attitude in patients with schizophrenia spectrum disorder receiving long-acting injectable antipsychotics.
    Linghui Zhang, Yubin Chen, Hong Yu +6
    BMC psychiatryPeer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthEurope PMCDOAJPMC
  2. Perceptions of psychiatrists toward long-acting injectable antipsychotics: A cross-sectional survey from Fujian, China
    Yixiang Zhou, Weijun Gu, Zhiqiang Cui +1
    PLOS OnePeer-reviewedCC BYFull textPsychiatry & mental healthPLOSEurope PMC
  3. Medical Decision‐Making Capacity in Early‐Stage Alzheimer Patients: Comparison With Healthy Controls and Benefit of Assistive Information
    Dilara Aylin Felice Vossberg, Vasilija Rolfes, Heiner Fangerau +1
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric SocietyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Conditional willingness to care for patients with Ebola virus disease: a qualitative study of risk-benefit perceptions and support needs of clinical students at a Ugandan medical school
    B. C. Nakabuubi, R. Nabunya, T. D. Ngabirano +8
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  5. Comparative Effectiveness of Antidepressants and Second-Generation Antipsychotics for Agitation Among Nursing Home Residents with Dementia
    Shiwei Liang, Kate L. Lapane, Brian R. Ott +4
    Journal of General Internal MedicinePeer-reviewedLicence not statedFull textPsychiatry & mental healthPMC
BibTeX
@article{rogers2026total,
  title = {{Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit}},
  author = {Brianne Rogers and Allison Olmsted and Millie Mo},
  journal = {Journal of Managed Care \& Specialty Pharmacy},
  year = {2026},
  month = nov,
  doi = {10.18553/jmcp.2026.32.11.1386},
  url = {https://doi.org/10.18553/jmcp.2026.32.11.1386},
}
RIS
TY  - JOUR
TI  - Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit
AU  - Brianne Rogers
AU  - Allison Olmsted
AU  - Millie Mo
PY  - 2026
DA  - 2026/11/01
JO  - Journal of Managed Care & Specialty Pharmacy
DO  - 10.18553/jmcp.2026.32.11.1386
UR  - https://doi.org/10.18553/jmcp.2026.32.11.1386
SN  - 2376-0540
SN  - 2376-1032
ER  -